DOCSLIB.ORG

T Cells + Naive CD4 , and IL-17A By

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
T Cells + Naive CD4 , and IL-17A By Human Dendritic Cells Stimulated via TLR7 and/or TLR8 Induce the Sequential Production of Il-10, IFN-γ, and IL-17A by Naive CD4 + T Cells This information is current as of September 23, 2021. Vincent Lombardi, Laurence Van Overtvelt, Stéphane Horiot and Philippe Moingeon J Immunol 2009; 182:3372-3379; ; doi: 10.4049/jimmunol.0801969 http://www.jimmunol.org/content/182/6/3372 Downloaded from References This article cites 28 articles, 8 of which you can access for free at: http://www.jimmunol.org/content/182/6/3372.full#ref-list-1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication by guest on September 23, 2021 *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Human Dendritic Cells Stimulated via TLR7 and/or TLR8 Induce the Sequential Production of Il-10, IFN-␥, and IL-17A by Naive CD4؉ T Cells Vincent Lombardi, Laurence Van Overtvelt, Ste´phane Horiot, and Philippe Moingeon1 Depending upon which TLRs are triggered, dendritic cells (DCs) may orient the differentiation of naive CD4؉ T cells toward either Th1, Th2, regulatory T cells, or the recently defined Th17 lineage. In this study, we report that a dual stimulation of TLR4 and TLR7/8 with LPS plus R848 leads human monocyte-derived DCs (MoDCs) to produce multiple pro- and anti-inflammatory cytokines, including IL-10, IL-12, and IL-23. Surprisingly, a significant variability in the up-regulation of these cytokines is observed in DCs obtained from various healthy donors, with approximately one of three being “high responders.” High responding MoDCs stimulated via TLR4 and TLR7/8 induce naive allogeneic CD4؉ T cell to secrete sequentially IL-10 and IFN-␥, and Downloaded from eventually IL-17A, whereas low responding MoDCs only stimulate IFN-␥ production. Both TLR7 and TLR8 play a central role in this phenomenon: TLR4 triggering with LPS up-regulates TLR7 expression on human MoDCs from high responders, silencing of either TLR7 or TLR8 mRNAs inhibits cytokine production in LPS plus R848-treated MoDCs, and plasmacytoid DCs consti- tutively expressing high levels of TLR7 induce the production of IL-10, IFN-␥, and IL-17A by naive T cells when stimulated with R848 alone. Collectively, our results illustrate the synergy between TLR4 and TLR7/8 in controlling the sequential production of ؉ regulatory and proinflammatory cytokines by naive CD4 T cells. The observed polymorphism in DC responses to such TLR- http://www.jimmunol.org/ mediated stimuli could explain differences in the susceptibility to infectious pathogens or autoimmune diseases within the human population. The Journal of Immunology, 2009, 182: 3372–3379. ollowing engagement with conserved microbial motifs (1– (5–9, 15–18). Th17 cells contribute to defense mechanisms against 3), TLRs play a critical role in inducing appropriate im- extracellular infectious pathogens but may also cause autoimmune mune responses against potential pathogenic agents (4). diseases (19–23). Immune responses to a pathogen or a danger F 2 Most particularly, signals provided to dendritic cells (DCs) signal are thus the end result of a balance between effector (proin- through selected TLRs are known to impact dramatically the cy- flammatory) and regulatory mechanisms involving those various ϩ tokine milieu in which the Ag is presented, thus leading to distinct CD4 T cell subsets at varying levels in the course of the response. by guest on September 23, 2021 patterns of naive CD4ϩ T cell differentiation (5–9). Th1 cells are In the present study, we document that both human monocyte- induced by IL-12-producing APCs, produce IFN-␥, and protect derived (MoDCs) and plasmacytoid DCs (pDCs) produce high lev- against intracellular bacteria or viruses. Chronic stimulation of Th1 els of IL-10, IL-12, and IL-23, albeit with unexpected variability cells may lead to autoimmunity (10). Th2 cells are elicited by depending upon individuals, when receiving a strong signal via IL-4-secreting APCs and produce IL-4, IL-5, and IL-13 cytokines. TLR7 and/or TLR8. High responding DCs support a sequential As such, they represent an effective defense mechanism against differentiation of naive CD4ϩ T cells into IL-10, IFN-␥, and IL- parasites, but are also associated with type I allergic inflammation 17-producing cells, likely to mediate both regulatory and proin- (11). CD4ϩ regulatory T cells (Tregs) capable of suppressing both flammatory functional programs, respectively. Th1 and Th2 immune responses are induced by DCs producing IL-10 and/or TGF-␤. Naturally occurring Tregs express the tran- Materials and Methods ␤ scription factor Foxp3 and produce IL-10 and/or TGF- , whereas Cells, reagents, and DC/T cocultures Th3 and Tr1 cells produce either TGF-␤ or IL-10, respectively (12–14). Recently, several studies established that DCs producing Heparinized blood from healthy volunteers (obtained from Etablissement Franc¸ais du Sang) was centrifuged over a Ficoll-Paque plus gradient (GE IL-1␤, IL-6, IL-23, and/or TGF-␤ induce the differentiation of a 8 ϩ Healthcare) to isolate PBMCs. To generate MoDCs, 10 cells were cul- new population of IL-17A-secreting CD4 Th cells termed Th17 tured at 37°C in 5% CO2 in a 75-ml plastic flask in 25 ml of culture medium (RPMI 1640 supplemented with 2 mM L-glutamine, 20 ␮g/ml gentamicin, 50 ␮M 2-ME, 1% nonessential amino acids (all obtained from Invitrogen) and 10% FBS (Gentaur)). After 2 h, nonadherent cells were Research and Development, Stallerge`nes SA, France removed, and adherent cells were further cultivated for 7 days in presence Received for publication June 17, 2008. Accepted for publication January 6, 2009. of recombinant human GM-CSF and IL-4, 80 and 25 ng/ml, respectively The costs of publication of this article were defrayed in part by the payment of page (Gentaur). After 7 days at 37°C, a pure population of DCs was obtained, ϩ charges. This article must therefore be hereby marked advertisement in accordance with more than 95% CD1a cells detected by flow cytometry using a with 18 U.S.C. Section 1734 solely to indicate this fact. FC500 cytometer and CXP analysis software (Beckman Coulter). To test 6 1 Address correspondence and reprint requests to Dr. Phillipe Moingeon, Research the effect of TLR ligands on DCs, 10 MoDCs were plated in a 24-well and Development, Stallergenes S.A., 6 Rue Alexis de Tocqueville, Antony Cedex plate in 1 ml of culture medium in presence of either medium, highly 92183, France. E-mail address: [email protected] purified LPS from Escherichia coli (1 ␮g/ml; InvivoGen), Resiquimod ␮ 2 Abbreviations used in this paper: DC, dendritic cell; CBA, cytometric bead array; (R848, 1 rusha g/ml; InvivoGen) or a combination of LPS plus R848. After 24 h at 37°C and 5% CO2, MoDCs were lysed to isolate total RNA MoDC, monocyte-derived dendritic cell; pDC, plasmacytoid dendritic cell; Treg, reg- ϩ ulatory T cell. or washed and cultured in a 24-well plate with allogeneic CD4 naive T cells at a 1:10 DC/T ratio in 1 ml of culture medium. Naive CD4ϩ T cells ϩ Copyright © 2009 by The American Association of Immunologists, Inc. 0022-1767/09/$2.00 were isolated from PBMCs by negative selection using a Dynal CD4 www.jimmunol.org/cgi/doi/10.4049/jimmunol.0801969 The Journal of Immunology 3373 Downloaded from http://www.jimmunol.org/ by guest on September 23, 2021 FIGURE 1. LPS plus R848-treated MoDCs trigger a sequential differentiation of naive CD4ϩ T cells toward IL-10, IFN-␥, and IL-17-producing T cells. MoDCs from nine healthy donors were treated for 24 h with either medium alone, LPS (1 ␮g/ml), R848 (1 ␮g/ml), or LPS plus R848, then washed and cultured with allogeneic naive CD4ϩ T cells. A, After 1, 3, and 6 days of culture, gene expression was quantified by real-time PCR. None of the cytokine genes was up-regulated in culture conditions lacking T lymphocytes. B, At day 3, 5, and 7, cells were restimulated for 4 h with a plate-coated anti-CD3 Ab in presence of Brefeldin A. Cells were surface stained with anti-CD4 and anti-CD25 Abs, fixed, and permeabilized to allow intracellular detection of IFN-␥, IL-10, and IL-17 by cytofluorometry. Data are displayed as dot plot histograms obtained after gating on CD4ϩ T cells and are representative of three independent experiments. 3374 TLR7/8-STIMULATED DCs INDUCE COMPLEX T CELL DIFFERENTIATION FIGURE 2. A combination of LPS plus R848 up-regulates cytokine produc- tion by MoDCs. Human MoDCs ob- tained from 26 healthy donors were cul- tured with either medium, ultra-pure LPS (1 ␮g/ml), R848 (1 ␮g/ml), or LPS Downloaded from plus R848. A, After 24 h, total RNA was isolated and IL-12, IL-23, IL-6, IL-1␤, TNF-␣, IL-10, IL-4, and TGF-␤ gene expression was evaluated by quantitative real-time PCR. B, Cytokine production was measured in culture supernatants by CBA (IL-12p70, IL-6, IL-1␤, and IL-10) http://www.jimmunol.org/ and ELISA (IL-23).
Load more

Recommended publications
  • Interleukin (IL)-12 and IL-23 and Their Conflicting Roles in Cancer
    Downloaded from http://cshperspectives.cshlp.org/ on October 2, 2021 - Published by Cold Spring Harbor Laboratory Press Interleukin (IL)-12 and IL-23 and Their Conflicting Roles in Cancer Juming Yan,1,2 Mark J. Smyth,2,3 and Michele W.L. Teng1,2 1Cancer Immunoregulation and Immunotherapy Laboratory, QIMR Berghofer Medical Research Institute, Herston 4006, Queensland, Australia 2School of Medicine, University of Queensland, Herston 4006, Queensland, Australia 3Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston 4006, Queensland, Australia Correspondence: [email protected] The balance of proinflammatory cytokines interleukin (IL)-12 and IL-23 plays a key role in shaping the development of antitumor or protumor immunity. In this review, we discuss the role IL-12 and IL-23 plays in tumor biology from preclinical and clinical data. In particular, we discuss the mechanism by which IL-23 promotes tumor growth and metastases and how the IL-12/IL-23 axis of inflammation can be targeted for cancer therapy. he recognized interleukin (IL)-12 cytokine composition whereby the a-subunit (p19, Tfamily currently consists of IL-12, IL-23, p28, p35) and b-subunit (p40, Ebi3) are differ- IL-27, and IL-35 and these cytokines play im- entially shared to generate IL-12 (p40-p35), IL- portant roles in the development of appropriate 23 (p40-p19), IL-27 (Ebi3-p28), and IL-35 immune responses in various disease conditions (p40-p35) (Fig. 1A). Given their ability to share (Vignali and Kuchroo 2012). They act as a link a- and b-subunits, it has been predicted that between the innate and adaptive immune system combinations such as Ebi3-p19 and p28-p40 through mediating the appropriate differentia- could exist and serve physiological function tion of naı¨ve CD4þ T cells into various T helper (Fig.
    [Show full text]
  • Cytokine Nomenclature
    RayBiotech, Inc. The protein array pioneer company Cytokine Nomenclature Cytokine Name Official Full Name Genbank Related Names Symbol 4-1BB TNFRSF Tumor necrosis factor NP_001552 CD137, ILA, 4-1BB ligand receptor 9 receptor superfamily .2. member 9 6Ckine CCL21 6-Cysteine Chemokine NM_002989 Small-inducible cytokine A21, Beta chemokine exodus-2, Secondary lymphoid-tissue chemokine, SLC, SCYA21 ACE ACE Angiotensin-converting NP_000780 CD143, DCP, DCP1 enzyme .1. NP_690043 .1. ACE-2 ACE2 Angiotensin-converting NP_068576 ACE-related carboxypeptidase, enzyme 2 .1 Angiotensin-converting enzyme homolog ACTH ACTH Adrenocorticotropic NP_000930 POMC, Pro-opiomelanocortin, hormone .1. Corticotropin-lipotropin, NPP, NP_001030 Melanotropin gamma, Gamma- 333.1 MSH, Potential peptide, Corticotropin, Melanotropin alpha, Alpha-MSH, Corticotropin-like intermediary peptide, CLIP, Lipotropin beta, Beta-LPH, Lipotropin gamma, Gamma-LPH, Melanotropin beta, Beta-MSH, Beta-endorphin, Met-enkephalin ACTHR ACTHR Adrenocorticotropic NP_000520 Melanocortin receptor 2, MC2-R hormone receptor .1 Activin A INHBA Activin A NM_002192 Activin beta-A chain, Erythroid differentiation protein, EDF, INHBA Activin B INHBB Activin B NM_002193 Inhibin beta B chain, Activin beta-B chain Activin C INHBC Activin C NM005538 Inhibin, beta C Activin RIA ACVR1 Activin receptor type-1 NM_001105 Activin receptor type I, ACTR-I, Serine/threonine-protein kinase receptor R1, SKR1, Activin receptor-like kinase 2, ALK-2, TGF-B superfamily receptor type I, TSR-I, ACVRLK2 Activin RIB ACVR1B
    [Show full text]
  • Selective Neutralization of IL-12 P40 Monomer Induces Death in Prostate Cancer Cells Via IL-12–IFN-Γ
    Selective neutralization of IL-12 p40 monomer induces death in prostate cancer cells via IL-12–IFN-γ Madhuchhanda Kundua, Avik Roya, and Kalipada Pahana,b,1 aDepartment of Neurological Sciences, Rush University Medical Center, Chicago, IL 60612; and bDivision of Research and Development, Jesse Brown Veterans Affairs Medical Center, Chicago, IL 60612 Edited by Xiaojing Ma, Weill Medical College, New York, NY, and accepted by Editorial Board Member Carl F. Nathan September 18, 2017 (received for review April 12, 2017) Cancer cells are adept at evading cell death, but the underlying p40 and p402 and developed an ELISA to monitor these cytokines mechanisms are poorly understood. IL-12 plays a critical role in the separately (10). Mouse squamous (KLN), prostate (TRAMP), early inflammatory response to infection and in the generation of breast (4T1), and liver hepatoma (Hepa) cells were cultured under T-helper type 1 cells, favoring cell-mediated immunity. IL-12 is com- serum-free condition for 48 h, followed by measurement of the posed of two different subunits, p40 and p35. This study underlines levels of p40, p402, IL-12, and IL-23 by sandwich ELISA. In gen- the importance of IL-12 p40 monomer (p40) in helping cancer cells to eral, the levels of IL-12 and IL-23 were very low compared with escape cell death. We found that different mouse and human cancer p40 and p402 in each of these cell lines (Fig. 1 A–C). Interestingly, cells produced greater levels of p40 than p40 homodimer (p402), the level of p40 was much higher than the levels of p402, IL-12, or IL-12, or IL-23.
    [Show full text]
  • Interleukin-12 Message in a Bottle. Clinical Cancer Research. a Cirella
    Published OnlineFirst October 1, 2020; DOI: 10.1158/1078-0432.CCR-20-3250 CLINICAL CANCER RESEARCH | CCR TRANSLATIONS Interleukin-12 Message in A Bottle Assunta Cirella1,2, Pedro Berraondo1,2,3, Claudia Augusta Di Trani1,2, and Ignacio Melero1,2,3,4 SUMMARY ◥ IL12 is a very potent cancer immunotherapy agent, but is difficult toxicity. Lipid-nanoparticle mRNA achieves IL12 expression and to harness safely if given systemically. Local gene transfer aims to efficacy in mouse models, opening the way to an ongoing trial. confine the effects of IL12 to malignant tissues, thus avoiding See related article by Hewitt et al. p. 6284 In this issue of Clinical Cancer Research, Hewitt and colleagues efficacy in mouse models (4), but insufficiently translated to the provide compelling results on the preclinical antitumor efficacy of lipid clinic in monotherapy approaches in terms of efficacy. At the nanoparticles containing mRNA encoding for IL12 (1). IL12 is a beginning of this quest, viral vectors dominated the scenario, but dimeric cytokine and a single chain version of the moiety has been it is nonviral gene transfer approaches that are currently the most constructed with a flexible linker. The immunotherapy agent for promising (Fig. 1). intratumoral delivery has been optimized as a result of several lines A relatively simple strategy has been the intralesional injection of of research. First, the lipid formulation is optimal for gene transfer of an expression plasmid encoding IL12 (tavokinogene telseplasmid) tumor cells and other cells in tumor stroma (ref. 2; AACR 2020 abstract into cutaneous or subcutaneous melanoma lesions followed CT032). Second, the RNA construction has been optimized to attain by in vivo electroporation to greatly augment gene transfer.
    [Show full text]
  • A Case of Pulmonary MALT Lymphoma Arising From
    http://dx.doi.org/10.4046/trd.2012.73.2.115 Case Report ISSN: 1738-3536(Print)/2005-6184(Online) Tuberc Respir Dis 2012;73:115-121 CopyrightⒸ2012. The Korean Academy of Tuberculosis and Respiratory Diseases. All rights reserved. A Case of Pulmonary MALT Lymphoma Arising from Lymphocytic Interstitial Pneumonitis Ki Hoon Park, M.D.1, Soon Seog Kwon, M.D., Ph.D.1, Myung Hee Chung, M.D., Ph.D.2, Jeana Kim, M.D., Ph.D.3, Hee Jung Lee, M.D., Ph.D.3, Ji-Won Min, M.D.4, Yong Hyun Kim, M.D.1 Departments of 1Internal Medicine, 2Radiology, and 3Pathology, Bucheon St. Mary's Hospital, The Catholic University of Korea School of Medicine, Bucheon, 4Department of Internal Medicine, Catholic Medical Center, The Catholic University of Korea School of Medicine, Seoul, Korea Pulmonary mucosa-associated lymphoid tissue-derived (MALT) lymphoma is a rare disease. This disorder is considered to be a model of antigen-driven lymphoma, which is driven either by autoantigens or by chronic inflammatory conditions. Low-grade B-cell MALT lymphoma may develop from a nonneoplastic pulmonary lymphoproliferative disorder, such as lymphocytic interstitial pneumonitis (LIP). A recent estimate predicts that less than 5% of LIP patients acquire malignant, low-grade, B-cell lymphoma. In Korea, there has been no previous report of malignant low-grade, B-cell lymphoma, acquired from LIP. Here, we present the case of a patient with LIP that developed into pulmonary MALT lymphoma, six years after diagnosis. Key Words: Lymphoma; Lymphoproliferative Disorders; Lung Diseases, Interstitial; Lymphoid Tissue Introduction orders, or autoimmune diseases is thought to be the ini- tial event leading to the development of MALT lympho- There are various lymphoproliferative disorders which ma5,6.
    [Show full text]
  • IL-1Β Induces the Rapid Secretion of the Antimicrobial Protein IL-26 From
    Published June 24, 2019, doi:10.4049/jimmunol.1900318 The Journal of Immunology IL-1b Induces the Rapid Secretion of the Antimicrobial Protein IL-26 from Th17 Cells David I. Weiss,*,† Feiyang Ma,†,‡ Alexander A. Merleev,x Emanual Maverakis,x Michel Gilliet,{ Samuel J. Balin,* Bryan D. Bryson,‖ Maria Teresa Ochoa,# Matteo Pellegrini,*,‡ Barry R. Bloom,** and Robert L. Modlin*,†† Th17 cells play a critical role in the adaptive immune response against extracellular bacteria, and the possible mechanisms by which they can protect against infection are of particular interest. In this study, we describe, to our knowledge, a novel IL-1b dependent pathway for secretion of the antimicrobial peptide IL-26 from human Th17 cells that is independent of and more rapid than classical TCR activation. We find that IL-26 is secreted 3 hours after treating PBMCs with Mycobacterium leprae as compared with 48 hours for IFN-g and IL-17A. IL-1b was required for microbial ligand induction of IL-26 and was sufficient to stimulate IL-26 release from Th17 cells. Only IL-1RI+ Th17 cells responded to IL-1b, inducing an NF-kB–regulated transcriptome. Finally, supernatants from IL-1b–treated memory T cells killed Escherichia coli in an IL-26–dependent manner. These results identify a mechanism by which human IL-1RI+ “antimicrobial Th17 cells” can be rapidly activated by IL-1b as part of the innate immune response to produce IL-26 to kill extracellular bacteria. The Journal of Immunology, 2019, 203: 000–000. cells are crucial for effective host defense against a wide and neutrophils.
    [Show full text]
  • Ocular HIV/AIDS Related Diseases (Initial and Follow-Up Evaluation)
    Ocular HIV/AIDS Related Diseases (Initial and Follow-up Evaluation) (Ratings: A: Most important, B: Moderately important, C: Relevant but not critical Strength of Evidence: I: Strong, II: Substantial but lacks some of I, III: consensus of expert opinion in absence of evidence for I & II) General - Initial Exam History Age (B:III) Ocular symptoms including laterality (A:III) Systemic symptoms (A:III) Complete review of systems (A:III) Prior ocular history (A:III) Prior medical history (A:III) Prior surgical history (B:III) History of other sexually transmitted diseases (A:III) History of AIDS-defining illnesses or complications (A:III) Method of HIV acquisition (B:III) Duration of HIV infection (A:III) Past and current risk factors – sexual behavior, intravenous drug abuse, transfusion history (A:III) Current anti-HIV regimen – duration and compliance (A:III) Current medications (A:II) Current CD4 count (A:II) Current viral load (A:II) Medication allergies (B:III) General - Initial Physical Exam General appearance (A:III) External examination – face, ocular adnexa (A:III) Lymphatics – preauricular and submandibular nodes (A:III) Visual acuity (A:III) Extraocular motility (A:III) Confrontation visual fields (A:III) Eyelids – lid closure, interpalpebral fissure height (B:III) Lacrimal gland (B:III) Evaluation of tear film – Schirmer, rose bengal and fluorescein staining (A:III) Nasolacrimal function (B:III) Slit-lamp examination o Eyelid margins (A:III) o Conjunctiva (A:III) o Sclera (A:III) o Cornea (A:III) o
    [Show full text]
  • The Role of IL-12/23 in T–Cell Related Chronic Inflammation; Implications of Immunodeficiency and Therapeutic Blockade
    The role of IL-12/23 in T–cell related chronic inflammation; implications of immunodeficiency and therapeutic blockade Authors: Anna Schurich, PhD1, Charles Raine, MRCP2, Vanessa Morris, MD, FRCP2 and Coziana Ciurtin, PhD, FRCP2 1. Division of Infection and Immunity, University College London, London 2. Department of Rheumatology, University College London Hospitals NHS Trust, London Corresponding authors: Dr. Coziana Ciurtin, Department of Rheumatology, University College London Hospitals NHS Trust, 3rd Floor Central, 250 Euston Road, London, NW1 2PG, email: [email protected]. Short title: The role of IL-12/23 in chronic inflammation The authors declare no conflicts of interest Abstract In this review, we discuss the divergent role of the two closely related cytokine, interleukin (IL)-12 and IL-23, in shaping immune responses. In light of current therapeutic developments using biologic agents to block these two pathways, a better understanding of the immunological function of these cytokines is pivotal. Introduction: The cytokines IL-12/23 are known to be pro-inflammatory and recognised to be involved in driving autoimmunity and inflammation. Antibodies blocking IL-12/23 have now been developed to treat patients with chronic inflammatory conditions such as seronegative spondyloarthropathy, psoriasis, inflammatory bowel disease, as well as multiple sclerosis. The anti-IL-12/23 drugs are very exciting for the clinician to study and use in these patient groups who have chronic, sometimes disabling conditions - either as a first line, or when other biologics such as anti-TNF therapies have failed. However, IL-12/23 have important biological functions, and it is recognised that their presence drives the body’s response to bacterial and viral infections, as well as tumour control via their regulation of T cell function.
    [Show full text]
  • Evolutionary Divergence and Functions of the Human Interleukin (IL) Gene Family Chad Brocker,1 David Thompson,2 Akiko Matsumoto,1 Daniel W
    UPDATE ON GENE COMPLETIONS AND ANNOTATIONS Evolutionary divergence and functions of the human interleukin (IL) gene family Chad Brocker,1 David Thompson,2 Akiko Matsumoto,1 Daniel W. Nebert3* and Vasilis Vasiliou1 1Molecular Toxicology and Environmental Health Sciences Program, Department of Pharmaceutical Sciences, University of Colorado Denver, Aurora, CO 80045, USA 2Department of Clinical Pharmacy, University of Colorado Denver, Aurora, CO 80045, USA 3Department of Environmental Health and Center for Environmental Genetics (CEG), University of Cincinnati Medical Center, Cincinnati, OH 45267–0056, USA *Correspondence to: Tel: þ1 513 821 4664; Fax: þ1 513 558 0925; E-mail: [email protected]; [email protected] Date received (in revised form): 22nd September 2010 Abstract Cytokines play a very important role in nearly all aspects of inflammation and immunity. The term ‘interleukin’ (IL) has been used to describe a group of cytokines with complex immunomodulatory functions — including cell proliferation, maturation, migration and adhesion. These cytokines also play an important role in immune cell differentiation and activation. Determining the exact function of a particular cytokine is complicated by the influence of the producing cell type, the responding cell type and the phase of the immune response. ILs can also have pro- and anti-inflammatory effects, further complicating their characterisation. These molecules are under constant pressure to evolve due to continual competition between the host’s immune system and infecting organisms; as such, ILs have undergone significant evolution. This has resulted in little amino acid conservation between orthologous proteins, which further complicates the gene family organisation. Within the literature there are a number of overlapping nomenclature and classification systems derived from biological function, receptor-binding properties and originating cell type.
    [Show full text]
  • Interleukin-12 Elicits a Non-Canonical Response in B16
    bioRxiv preprint doi: https://doi.org/10.1101/608828; this version posted August 3, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 1 Interleukin-12 elicits a non-canonical response in B16 2 melanoma cells to enhance survival. ∗ y 3 Christina N. Byrne-Hoffman , Wentao Deng , Owen McGrathz, Peng Wang,∗ Yon Rojanasakul,∗ David J. Klinke IIyzx 4 August 3, 2019 5 Correspondence: Dr. David J. Klinke II, Department of Chemical and Biomedical Engi- 6 neering, P.O. Box 6102, West Virginia University, Morgantown, WV 26506-6102. 7 Tel: (304) 293-9346 E-mail: [email protected] 8 9 10 Abstract 11 Within tissues, cells secrete protein signals that are subsequently interpreted by 12 neighboring cells via intracellular signaling networks to coordinate a cellular response. 13 However, the oncogenic process of mutation and selection can rewire these signaling 14 networks to confer a fitness advantage to malignant cells. For instance, the melanoma 15 cell model (B16F0) creates a cytokine sink for Interleukin-12 (IL-12) to deprive neigh- 16 boring cells of this important extracellular signal for sustaining anti-tumor immunity. 17 Alternatively, oncogenesis may also rewire intracellular signaling networks. To test this 18 concept, we asked whether IL-12 provides an intrinsic advantage to B16F0 melanoma 19 cells. Functionally, stimulation with IL-12 promoted the survival of B16F0 cells that 20 were challenged with a cytotoxic agent but had no rescue effect on normal Melan-A 21 melanocytes.
    [Show full text]
  • Immunology of Il-12: an Update on Functional Activities and Implications for Disease
    EXCLI Journal 2020;19:1563-1589 – ISSN 1611-2156 Received: November 13, 2020, accepted: December 07, 2020, published: December 11, 2020 Review article: IMMUNOLOGY OF IL-12: AN UPDATE ON FUNCTIONAL ACTIVITIES AND IMPLICATIONS FOR DISEASE Karen A.-M. Ullrich#1, Lisa Lou Schulze#1, Eva-Maria Paap1, Tanja M. Müller1, Markus F. Neurath1, Sebastian Zundler1,* # Shared first authorship 1 Department of Medicine and Deutsches Zentrum Immuntherapie, University Hospital Erlangen, Friedrich-Alexander- University Erlangen-Nuremberg, Germany * Corresponding author: Dr. med. Sebastian Zundler, Department of Medicine and University Hospital Erlangen, Ulmenweg 18, D-91054 Erlangen, Germany, Phone: 09131/85-35000, E-mail: [email protected] http://dx.doi.org/10.17179/excli2020-3104 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/). ABSTRACT As its first identified member, Interleukin-12 (IL-12) named a whole family of cytokines. In response to pathogens, the heterodimeric protein, consisting of the two subunits p35 and p40, is secreted by phagocytic cells. Binding of IL-12 to the IL-12 receptor (IL-12R) on T and natural killer (NK) cells leads to signaling via signal transducer and activator of transcription 4 (STAT4) and subsequent interferon gamma (IFN-γ) production and secretion. Signaling downstream of IFN-γ includes activation of T-box transcription factor TBX21 (Tbet) and induces pro-inflamma- tory functions of T helper 1 (TH1) cells, thereby linking innate and adaptive immune responses. Initial views on the role of IL-12 and clinical efforts to translate them into therapeutic approaches had to be re-interpreted following the discovery of other members of the IL-12 family, such as IL-23, sharing a subunit with IL-12.
    [Show full text]
  • Immunoglobulin and T Cell Receptor Genes: IMGT(®) and the Birth and Rise of Immunoinformatics Marie-Paule Lefranc
    Immunoglobulin and T Cell Receptor Genes: IMGT(®) and the Birth and Rise of Immunoinformatics Marie-Paule Lefranc To cite this version: Marie-Paule Lefranc. Immunoglobulin and T Cell Receptor Genes: IMGT(®) and the Birth and Rise of Immunoinformatics. Frontiers in Immunology, Frontiers, 2014, 5, pp.22. 10.3389/fimmu.2014.00022. hal-00957520 HAL Id: hal-00957520 https://hal.archives-ouvertes.fr/hal-00957520 Submitted on 28 May 2021 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Distributed under a Creative Commons Attribution| 4.0 International License CLASSIFICATION ARTICLE published: 05 February 2014 doi: 10.3389/fimmu.2014.00022 Immunoglobulin and T cell receptor genes: IMGT® and the birth and rise of immunoinformatics Marie-Paule Lefranc* The International ImMunoGenetics Information System® (IMGT®), Laboratoire d’ImmunoGénétique Moléculaire (LIGM), Institut de Génétique Humaine, UPR CNRS, Université Montpellier 2, Montpellier, France Edited by: IMGT®, the international ImMunoGeneTics information system®1, (CNRS and Université Kendall A. Smith, Weill Cornell Montpellier 2) is the global reference in immunogenetics and immunoinformatics. By its Medical College of Cornell University, ® USA creation in 1989, IMGT marked the advent of immunoinformatics, which emerged at ® Reviewed by: the interface between immunogenetics and bioinformatics.
    [Show full text]